Instructions for Noben (Idebenone) 30 capsules 30 mg
caps. 30 mg: 10, 20, 30, 60, 90 or 120 pcs
Gelatine solid capsules, size №1, yellow; the contents of the capsules are powder with granules or powder of yellow or yellow-orange colour with indentations from light yellow to orange, white indentations are allowed.
idebenon 30 mg
Auxiliary substances: lactose monohydrate, cellulose microcrystalline (type 101), potato starch, povidone (polyvinylpyrrolidone low molecular medical or plasdon) (K17), magnesium stearate.
Capsule shell composition: titanium dioxide (E171), quinoline yellow dye (E104), sunlit sunset yellow dye (E110), gelatin.
10 pcs - packages of box contour (1) - cardboard packs.
10 pcs - packages of box contour (2) - cardboard packs.
10 pcs - box-type contour (3) packages - cardboard packs.
10 pcs - packages of box contour (6) - cardboard packs.
10 pcs - box-type contour (9) packages - cardboard packs.
10 pcs - box-type contour (12) packages - cardboard packs.
Clinical-pharmacological groups / Group affiliation
The drug Noben should be stored in a place inaccessible to children, protected from light at a temperature not higher than 30 ° C.
Best before date
Shelf life is 3 years. Do not apply after expiry date.
- treatment of cognitive and behavioral disorders as a result of vascular and degenerative brain pathologies;
- treatment of cognitive and behavioral disorders against the background of cerebrovascular insufficiency and age-related involutional changes of the brain.
Method of use, course and dosage
The drug Noben is taken inside, after a meal (the last take not later than 17 h).
Prescribed 30 mg (1 caps) 2-3 times/day. The length of treatment is determined by the doctor.
Application for kidney disorders
It is contraindicated in chronic kidney failure.
Use in children Idebenone
The use of the preparation in the age of up to 18 years is contraindicated.
Nosology Noben (ICD codes)
Personality and behavioural disorders caused by disease, damage or brain dysfunction
Effects of cerebrovascular disease